Form 4 for IDYA IDEAYA Biosciences, Inc.
Accepted 2026-02-02 00:00:00 ET · period of report 2026-01-30 · accession 0001610717-26-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-02 | 2024-11-29+ | IDYA | Ruiz Briseno Andres | See Remarks | A - Grant | $19.15 | +1,935 | 26.5K | +8% | +$37.1K |
| D | 2026-02-02 | 2026-01-30 | IDYA | Ruiz Briseno Andres | See Remarks | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-29 | A | A | 682 | $23.26 | 25,213 | D | — | — | |
| 2 | Common | Common Stock | 2025-11-28 | A | A | 1,253 | $16.91 | 26,466 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2026-01-30 | A | A | 80,000 | $0.00 | 80,000 | D | $32.19 · — to 2036-01-30 | 80,000 Common Stock | (F2) 25% of the shares subject to the option vest on the first anniversary measured from January 1, 2026 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |